{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:45:23Z","timestamp":1759401923963},"reference-count":27,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.vaccine.2011.06.007","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T16:47:46Z","timestamp":1308934066000},"page":"5584-5590","source":"Crossref","is-referenced-by-count":7,"title":["Humoral immunogenicity of an HIV-1 envelope residue 649\u2013684 membrane-proximal region peptide fused to the plague antigen F1-V"],"prefix":"10.1016","volume":"29","author":[{"given":"Nobuyuki","family":"Matoba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namrata Rahul","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsafrir S.","family":"Mor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.06.007_bib0005","unstructured":"Global report: UNAIDS report on the global AIDS epidemic | 2010. Joint United Nations Programme on HIV\/AIDS; 2010."},{"issue":"March (7286)","key":"10.1016\/j.vaccine.2011.06.007_bib0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature08757","article-title":"Targeting early infection to prevent HIV-1 mucosal transmission","volume":"464","author":"Haase","year":"2010","journal-title":"Nature"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.06.007_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"10","author":"McMichael","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.06.007_bib0020","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/eji.200939269","article-title":"Strategies for optimizing targeting and delivery of mucosal HIV vaccines","volume":"39","author":"Ahlers","year":"2009","journal-title":"Eur J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.06.007_bib0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm0197-42","article-title":"Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier","volume":"3","author":"Bomsel","year":"1997","journal-title":"Nat Med"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.06.007_bib0030","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.4049\/jimmunol.166.10.6257","article-title":"Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1","volume":"166","author":"Alfsen","year":"2001","journal-title":"J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.06.007_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ceca.2007.04.011","article-title":"The binding of HIV-1 gp41 membrane proximal domain to its mucosal receptor, galactosyl ceramide, is structure-dependent","volume":"43","author":"Yu","year":"2008","journal-title":"Cell calcium"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.06.007_bib0040","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1091\/mbc.E05-03-0192","article-title":"HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer","volume":"16","author":"Alfsen","year":"2005","journal-title":"Mol Biol Cell"},{"issue":"July (28)","key":"10.1016\/j.vaccine.2011.06.007_bib0045","doi-asserted-by":"crossref","first-page":"25649","DOI":"10.1074\/jbc.M200554200","article-title":"HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide","volume":"277","author":"Alfsen","year":"2002","journal-title":"J Biol Chem"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.06.007_bib0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1467-7652.2008.00381.x","article-title":"Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR(649\u2013684)","volume":"7","author":"Matoba","year":"2009","journal-title":"Plant Biotechnol J"},{"issue":"3","key":"10.1016\/j.vaccine.2011.06.007_bib0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157016208784324994","article-title":"Transcytosis-blocking Abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes","volume":"6","author":"Matoba","year":"2008","journal-title":"Curr HIV Res"},{"issue":"June (23)","key":"10.1016\/j.vaccine.2011.06.007_bib0060","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.vaccine.2006.03.045","article-title":"Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649\u2013684), a mucosal subunit HIV\/AIDS vaccine candidate","volume":"24","author":"Matoba","year":"2006","journal-title":"Vaccine"},{"issue":"September (37)","key":"10.1016\/j.vaccine.2011.06.007_bib0065","doi-asserted-by":"crossref","first-page":"13584","DOI":"10.1073\/pnas.0405297101","article-title":"A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs","volume":"101","author":"Matoba","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.06.007_bib0070","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1586\/erv.09.129","article-title":"Prospects for new plague vaccines","volume":"8","author":"Feodorova","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"November (Suppl 4)","key":"10.1016\/j.vaccine.2011.06.007_bib0075","doi-asserted-by":"crossref","first-page":"D56","DOI":"10.1016\/j.vaccine.2009.07.068","article-title":"Plague","volume":"27","author":"Williamson","year":"2009","journal-title":"Vaccine"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.06.007_bib0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2249.2007.03452.x","article-title":"The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses","volume":"149","author":"Kingston","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"January\u2013March (1)","key":"10.1016\/j.vaccine.2011.06.007_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039463200902200115","article-title":"Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system","volume":"22","author":"Del Prete","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2011.06.007_bib0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1073\/pnas.0510014103","article-title":"Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system","volume":"103","author":"Santi","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2011.06.007_bib0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0003-2697(89)90602-7","article-title":"Calculation of protein extinction coefficients from amino acid sequence data","volume":"182","author":"Gill","year":"1989","journal-title":"Anal Biochem"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2011.06.007_bib0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-3083.1995.tb03653.x","article-title":"Systemic and secretory humoral immunity in the normal human vaginal tract","volume":"42","author":"Hocini","year":"1995","journal-title":"Scand J Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.06.007_bib0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2004.05.007","article-title":"Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells","volume":"20","author":"Yoshida","year":"2004","journal-title":"Immunity"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2011.06.007_bib0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00281-006-0054-z","article-title":"IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity","volume":"28","author":"Yoshida","year":"2006","journal-title":"Springer Semin Immunopathol"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2011.06.007_bib0115","doi-asserted-by":"crossref","first-page":"11526","DOI":"10.1128\/JVI.01111-08","article-title":"Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A","volume":"82","author":"Wright","year":"2008","journal-title":"J Virol"},{"issue":"October (43)","key":"10.1016\/j.vaccine.2011.06.007_bib0120","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1016\/j.vaccine.2010.08.009","article-title":"Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen","volume":"28","author":"Jain","year":"2010","journal-title":"Vaccine"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.06.007_bib0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11904-009-0003-2","article-title":"Novel humanized murine models for HIV research","volume":"6","author":"Denton","year":"2009","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.06.007_bib0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11904-009-0035-7","article-title":"Use of nonhuman primate models to develop mucosal AIDS vaccines","volume":"7","author":"Genesca","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.06.007_bib0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0897.2010.00967.x","article-title":"Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection","volume":"65","author":"Merbah","year":"2011","journal-title":"Am J Reprod Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11008711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11008711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T03:06:40Z","timestamp":1560308800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11008711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":27,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0264410X11008711"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}